ArticleOncogene2016
Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax.
R Bajpai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
70 papers cite itlatest 60 shown
this papercites it